chrisvoncsefalvay/vaers-outcomes huggingface dataset:
51 yo F complaining of nausea. EMS eval. Pt admitted to not eating anything that day prior to receiving her vaccine. BP 89/62. 4-lead, unremarkable. BP 108/62. Pt refused transport and left under her own power.
pt recv vax 9MAY97 & w/in a wk of vax pt exp fever of 104 excruciating multiple joint pain;
Fever; Red hard rash at the injection site; Red hard rash at the injection site; Red hard rash at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (Red hard rash at the injection site), VACCINATION SITE RASH (Red hard rash at the injection site), VACCINATION SITE ERYTHEMA (Red hard rash at the injection site) and PYREXIA (Fever) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021C21A and 021C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 15-Jun-2021, the patient experienced VACCINATION SITE INDURATION (Red hard rash at the injection site), VACCINATION SITE RASH (Red hard rash at the injection site) and VACCINATION SITE ERYTHEMA (Red hard rash at the injection site). On 17-Jun-2021, the patient experienced PYREXIA (Fever). The patient was treated with IBUPROFEN at a dose of UNK dosage form. At the time of the report, VACCINATION SITE INDURATION (Red hard rash at the injection site), VACCINATION SITE RASH (Red hard rash at the injection site), VACCINATION SITE ERYTHEMA (Red hard rash at the injection site) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Jun-2021, Body temperature: 99.8 (High) The fever was measured at 99.8F.
CHRONIC HORRIBLE tinnitus that will not stop!!! It began about an hour and a half after the shot and has not stopped for over a month now! It is so LOUD and continuous that it is keeping me from sleeping at all and is affecting my ability to concentrate, it is negatively affecting EVERY aspect of my life. It has been mostly in my left ear but has recently been going up and down in my right ear also. I was forced to get vaccinated or be fired by my employer despite the fact that I had full natural immunity. I tested positive for antibodies the day before  the vaccine, 17 months after having Covid!!!! My employer would not hear a word about natural immunity, said I was a danger to the community, and said I would be fired if I didn't get vaccinated. I wish now that I would have just let them fire me! I am very worried about my hearing and my health in general as it seems to just be getting worse. I will be undergoing a brain scan next week, seeing an audiologist and further testing after that in an attempt to end this nightmare.
Fever 102 F; severe headache; chills; body ache and bone pain; fatigue; nausea.
It was brought to our attention that the third hepatitis B vaccine dose was administered too soon. The patient received his first does on 9/21/15, a second dose on 11/17/2015 and then a third dose on 12/29/2015. It appears that the first dose was not charted in the patients immunizations and the person that administered the third dose did not check CAIR to verify what does he was on. Pt did not report any harmful side effects from the vaccines given. Per CAIR, the third dose was supposed to be given on 2/23/2016. We have since been education staff on the importance of checking the patients chart and CARI records to confirm the vaccine schedule.
Fast Heart Beat; Tightness in chest on left side; knee swelled; lower right back ache; Sore muscles; shoulder pain; headache; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Fast Heart Beat), CHEST DISCOMFORT (Tightness in chest on left side), JOINT SWELLING (knee swelled), BACK PAIN (lower right back ache) and MYALGIA (Sore muscles) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0121N20A and 011120A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension and Drug allergy (sulfur). Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), LISINOPRIL and LOVASTATIN for an unknown indication.   On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Feb-2021, the patient experienced HEART RATE INCREASED (Fast Heart Beat), CHEST DISCOMFORT (Tightness in chest on left side), JOINT SWELLING (knee swelled), BACK PAIN (lower right back ache), MYALGIA (Sore muscles), ARTHRALGIA (shoulder pain) and HEADACHE (headache). At the time of the report, HEART RATE INCREASED (Fast Heart Beat), CHEST DISCOMFORT (Tightness in chest on left side), JOINT SWELLING (knee swelled), BACK PAIN (lower right back ache), MYALGIA (Sore muscles), ARTHRALGIA (shoulder pain) and HEADACHE (headache) outcome was unknown.             Treatment details were not provided.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the reported events, a causal relationship cannot be excluded.
Low estrogen; can't concentrate/can't focus; can't sleep; depressed; has anxiety; This is a spontaneous report from a contactable consumer. This consumer reported same events under same suspect product for 10 patients this is one of 10 reports:  A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced low oestrogen, can't concentrate/can't focus, can't sleep, depressed, and has anxiety. It was reported that the reporter who believed that she received the Moderna vaccine, stating that since receiving her 2nd dose in April, she had low estrogen, cannot sleep, cannot focus, depressed, has anxiety and cannot concentrate. She was tested and test proved that she has low estrogen. She went on to state that she was aware of 10 people who experienced the similar reactions. 5 of which are withheld 5 and she is withheld and did not mention the nationality of the other 5. When she was requested the date of vaccination and LOT number/EXP Date for the Moderna vaccine, patient realized that she called the wrong number because she had received both doses of the Pfizer vaccine. On an unspecified date, the patient underwent lab tests and procedures which included Estrogen: low. The outcome of all the events were unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : PFIZER_INC-202101533632
Injection site pain  Fever of 102F Body chills/aches  Headache  Got vaccine at 1020 and developed arm pain at 1300 and fever and other symptoms at 1900. All resolved by morning except headache (lasted two days)
was completely in menopause and 2 days after the first shot I started my period heavy for 10 days; was completely in menopause and 2 days after the first shot I started my period heavy for 10 days; diarrhea(liquid); This is a spontaneous report from a contactable consumer (patient).  A 49-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE),  via an unspecified route of administration, administered in left arm on 11Aug2021 12:00 (Batch/Lot number was not reported) as DOSE 1, SINGLE for COVID-19 immunisation. Medical history included menopause and COVID-19 (COVID prior vaccination) on unspecified dates.  The patient was not pregnant at the time of vaccination and no other vaccine was received in four weeks. There were no concomitant medications. The patient previously took amoxicillin and experienced allergies. On 13Aug2021, the patient experienced was completely in menopause and 2 days after the first shot  she started her period heavy for 10 days  (medically significant). On unspecified date in 20201, the patient also had diarrhea (liquid) (medically significant) for three weeks after the first shot.  There were no treatments for the events. Patient had not tested for COVID post vaccination. The outcome of the events completely in menopause and 2 days after the first shot I started my period heavy for 10 days was recovered on 23Aug2021 while diarrhea (liquid) was recovered unspecified date in 2021.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow-up.
Information has been received from a nurse practitioner concerning a 19 year old female patient with no pertinent medical history or no known drug allergies who on 04-FEB-2009 was vaccinated intramuscularly with the first dose of GARDASIL (Lot # 661766/0652X).  There was no concomitant medication.  On 07-FEB-2009 the patient developed enlarged lymph nodes on her neck.  The nurse practitioner saw the patient on 16-FEB-2009 and the lymph node was about 1 cm in diameter.  She had been taking AUGMENTIN, to treat the symptom.  Subsequently, on an unspecified date the patient recovered.  Additional information has been requested.
Had the shingles vaccine and still got shingles/Suspected vaccination failure; Got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   The reporter considered the vaccination failure and shingles to be possibly related to Shingrix.     Additional Information: GSK Receipt Date: 21-FEB-2023 Reporter's Comment: Reporter's Comment: This case was reported by a patient via interactive digital media. The reporter reported that his/her friend received Shingles vaccine. The reporter stated that the patient still got the shingles and so much for a vaccine, just like the Covid vaccine. Additional supportive information: This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
This spontaneous report received from a consumer, concerns a 62-year-old female patient who received the Moderna COVID-19 vaccine (mRNA-1273) and experienced chills, fatigue, headache and muscle aches. No medical history or concomitant medications reported. On Feb 5, 2021, prior to the onset of events, patient received the first of two planned doses of mRNA-1273 (batch/lot# 016M20A), intramuscularly, for prophylaxis of COVID-19 infection. On Mar 4, 2021, patient received the second of two planned doses of mRNA-1273 (batch/lot# 036A21A), intramuscularly, for prophylaxis of COVID-19 infection. On an unknown date, patient experienced chills, fatigue, headache and muscle aches. No treatment information provided. Action taken with mRNA-1273 in response to the events not reported. The outcome of chills, fatigue, headache, muscle aches: unknown.
Case number PHEH2014US025139, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 28 year old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 20 Nov 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was in between 46 to 49 degree F during excursion. No previous events reported after the maladministration.
I received my vaccine at noon and after a couple of hours I had severe muscle pain in both legs. I was very fatigued the rest of the day and had a headache. During the night I had chills and was dizzy. My temp was only 99.1 but I felt awful. I still had a temp this morning (day 2)  No dizziness but I do have an awful headache and my arm is very sore where I received the injection.
Dry throat; Coughing (5minutes); Flushed; Face and cheeks were getting puffy; Metallic taste in her mouth; Her head started feeling like she was developing a head cold; Ears felt like they were blocked up/congested; Felt dizzy; Face, cheeks, and forehead was red; felt droopy; Felt a little weak; Her arm now started feeling sore; Arm has a little lump on it; Felt fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DRY THROAT (Dry throat), COUGH (Coughing (5minutes)), FLUSHING (Flushed), SKIN SWELLING (Face and cheeks were getting puffy) and DYSGEUSIA (Metallic taste in her mouth) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was reported by reporter.  Concomitant products included TRIAMCINOLONE ACETONIDE (NASACORT), LORATADINE, FAMOTIDINE and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced DRY THROAT (Dry throat), COUGH (Coughing (5minutes)), FLUSHING (Flushed), SKIN SWELLING (Face and cheeks were getting puffy), DYSGEUSIA (Metallic taste in her mouth), NASOPHARYNGITIS (Her head started feeling like she was developing a head cold), EAR CONGESTION (Ears felt like they were blocked up/congested), DIZZINESS (Felt dizzy), ERYTHEMA (Face, cheeks, and forehead was red), FEELING ABNORMAL (felt droopy), ASTHENIA (Felt a little weak), PAIN IN EXTREMITY (Her arm now started feeling sore), VACCINATION SITE MASS (Arm has a little lump on it) and FATIGUE (Felt fatigue). On 19-Mar-2021, DRY THROAT (Dry throat), COUGH (Coughing (5minutes)), FLUSHING (Flushed), SKIN SWELLING (Face and cheeks were getting puffy), DYSGEUSIA (Metallic taste in her mouth), NASOPHARYNGITIS (Her head started feeling like she was developing a head cold), EAR CONGESTION (Ears felt like they were blocked up/congested), DIZZINESS (Felt dizzy), ERYTHEMA (Face, cheeks, and forehead was red), FEELING ABNORMAL (felt droopy), ASTHENIA (Felt a little weak), PAIN IN EXTREMITY (Her arm now started feeling sore) and FATIGUE (Felt fatigue) had resolved. At the time of the report, VACCINATION SITE MASS (Arm has a little lump on it) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments
3 hrs later I felt like I had the flu. Chills, nausea, no rash, muscle aches. My blood sugar was very low. After 5 days it seemed to get better. A couple weeks later I felt tired and felt abdominal pain. nausea, serve vomiting, serve diarrhea, I passed out on the bathroom floor. I went to the ER I had bloody diarrhea. Serve left side colonial pain
On 09/15/19 patient developed large red circle on upper shoulder area, next to the site of administration. Patient presented to the pharmacy 09/16/19 concerned about the area and complained that it hurt to touch as well. I told the patient to take Benadryl to help ease the reaction and to follow up with her PCP.
Patient received her second booster too soon. She was due 5/27 and was given the vaccine 4/19. About 42 days early. No known adverse events. Patient was made aware of the error and was directed to the app as well to keep an eye on adverse events.
Pt c/o Headache, dizziness, body aches, weakness starting last night, and symptoms got worse this morning. Pt received 1st vaccine dose 05 Jan, 2nd dose 3 Feb. Pt denies sob/v.  No Known Drug Allergies  CHIEF COMPLAINT & HPI:  21 yo M with Headache, dizziness, body aches, weakness starting last night, and symptoms got worse this morning. Pt received 1st vaccine dose 05 Jan, 2nd dose 3 Feb. Pt denies sob/v.
DVT of bilateral lower extremities and bilateral pulmonary edema.  Treated with apixaban 5 mg per standard dosing. Hospitalized 4/27/2021 and discharged 5/4/2021.  Patient convalescing at home.  Tentative return to work date 5/24/2021. Follow-up hematologist consult due on 5/10/2021 and follow-up pulmonary consult due on 5/19/2021.
Pt received vaccination thru employer.  Approximately 10 days later, she developed erythema nodosum of the legs.
Day"0"date of vax-firmness below(distal to)inject site.Day"1"-some fever in AM,headache,spread of swelling.Day"2"-headache.Day 3(today):Exam:mild cellulitis,not really red;sl warm,not hot,visible palpable swelling;almost encircles arm..WORM
Pt w LOC and 2 episodes of tonic  clonic movement immediately following injection of HPV and Boostrix.  LOC x 45 sec.  Immediately following gaining consciousness patient was appropriate w questions. Patient notes prior to syncope room began spinning.  Vision darkened.  Diaphoretic following episode.  Minutes later as per patient feeling fine.
10-5-09 Pt rec'd flu vaccine in left deltoid 10-8-09 Pt called clinic due to itching and redness. NP told her to take BENADRYL. Today 10/9/09 Pt went to PCP and he gave her a MEDROL DOSE PACK.
This case was reported by a consumer via call center representative and described the occurrence of adverse reaction in a elderly female patient who received SHINGRIX for prophylaxis. The patient's past medical history included cancer (no spleen due to cancer). On 14th May 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown. It was unknown if the reporter considered the adverse reaction to be related to SHINGRIX. Additional details were provided as follows: This case was reported by the husband who reported for her wife. The age at the vaccination was not reported. The patient received SHINGRIX vaccine and experienced slight reaction. The reporter reported that initial reason he called GlaxoSmithKline was the lack of availability for the vaccine. This case has been linked to US2018190915 (husband's case) and US2018GSK229702 (same patient).
24 y/o male, received primary SPV on 24 Jan 2012. Noted onset of pustular lesions on forehead, left thigh, and gluteus by 9 Feb 12.
recently have COVID (diagnosed 1/21/2022 - 3 weeks and 6 days, Fever (States 101.4F temp starting around 0100.  Chills)
17 yo given Janssen only approved for 18 and over - given at pop up clinic at local church no adverse events related to getting Janssen known
child complained of itching at site with slight rash at site about 14 minutes after receiving injection.  At 20 minutes after receiving injection child complained of itching sensation in back of throat.
The patient came in today to receive their 2nd dose of Pfizer. The patient completed their forms and had the vaccine processed through insurance. I called the patient back to the immunization room and verified the patients information, answered concerns/questions, and also verified that the proper vaccine was going to be administered both by myself and the patient using the actual vial drawn upon. During administration into the patient's left arm an indeterminate amount of vaccine was delivered due to the needle not being securely fastened to the syringe. I was somewhat confident that at least half the dose was administered and the patient waited the 10-15 minute period. During this time, I began looking up recommendations for errors such as this and decided that I could not, with certainty, certify that I had given at least half the Pfizer dose. Due to the CDC's administration errors and deviations guidelines on accidental dosing errors, specifically dealing with lower than half volumes or indeterminate volumes, it is recommended to give the authorized volume as soon as possible in the opposite arm. I decided it would be prudent to administer another dose, so I called the patient, whom had already drove home, and had them return to the pharmacy for a correct dose. I did, in fact, give this correct, authorized dose to the individual in their opposite arm (right). No adverse reaction or harm was viewed after having the patient wait another 10-15 minute period at the pharmacy.
Patient received Moderna booster dose. She received the 23rd dose out of the vial. It was later found out that the vial is only supposed to be punctured a max of 20 times. Patient has reported no adverse events.
2/6/21 my arm began itching at injection sight and was red and round and quite large and remains at this time on the arm at 12:00pm 2/7/21
Typical sore arm for 48 hrs that responded to Advil.  In addition to that, on post day 5, experienced extreme sun-sensitivity and initially had slight itch to face, that developed to slight raised rash.  Was outdoors for 3 hrs and clothing-covered except for face.  Have been using allegra, which has helped, and Aquaphor.  This is day 3 and feels like subsiding, although still ?tight? feeling.   There has been NO changes to soaps, cleansers, moisturizers, etc.    SPECIAL NOTE: I have a darker complexion and seldom burn, so sun-sensitivity is not typical for me.  Thought may be too coincidental with recent vaccine,  and after I researched websites and did not see this as a possible side effect, decided to report.
Had vaccines on 12/11/12, DAPTACEL and PEDVAXHIB. Developed fine rash on the next day. Advised to watch for urticarial lesions as discussed at Dr's appt today.
Patient vaccinated against then tested positive for COVID-19. We unfortunately do not have any data on vaccinations except for the manufacturer and date.